🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Warren Mason

University of Toronto

ORCID: 0000-0001-9107-2242

Also affiliated with Princess Margaret Cancer Centre

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial”.

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

The Lancet Oncology(2009)10.1016/s1470-2045(09)70025-7
N/A
1.3DataRank · unranked
7738 citations

Monika E. Hegi, Martin J. van den Bent, Martin JB Taphoorn, Robert C. Janzer, Samuel K. Ludwin +25 more

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

New England Journal of Medicine(2005)10.1056/nejmoa043331
N/A
1.3DataRank · unranked
7181 citations

Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller +15 more

Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation

Journal of Neuro-Oncology(2022)10.1007/s11060-022-04088-3
N/A
0.782DataRank · unranked
16 citations

Jacob Schlossman, Soroush Shabani, Catalina Raymond, Hiroyuki Tatekawa, Lauren E. Abrey +10 more